APA (7th ed.) Citation

M, O., K, T., K, Y., K, E., H, H., M, K., . . . K, A. (2026). Gefitinib-Induced Heart Failure Confirmed by a Rechallenge in a Patient with EGFR-Mutated Lung Adenocarcinoma. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.7140-26

Chicago Style (17th ed.) Citation

M, Ohtaka, et al. "Gefitinib-Induced Heart Failure Confirmed by a Rechallenge in a Patient with EGFR-Mutated Lung Adenocarcinoma." Internal Medicine (Tokyo, Japan) 2026. https://doi.org/10.2169/internalmedicine.7140-26.

MLA (9th ed.) Citation

M, Ohtaka, et al. "Gefitinib-Induced Heart Failure Confirmed by a Rechallenge in a Patient with EGFR-Mutated Lung Adenocarcinoma." Internal Medicine (Tokyo, Japan), 2026, https://doi.org/10.2169/internalmedicine.7140-26.